These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 16227086

  • 1. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
    Tedder TF, Poe JC, Haas KM.
    Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
    [Abstract] [Full Text] [Related]

  • 2. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity.
    Fujimoto M, Sato S.
    J Dermatol Sci; 2007 Apr; 46(1):1-9. PubMed ID: 17223015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L.
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [Abstract] [Full Text] [Related]

  • 5. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
    Sato S, Tuscano JM, Inaoki M, Tedder TF.
    Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K, Martin SW, Pogue SL, Silver K, Peng K, Takatsu K, Goodnow CC.
    J Exp Med; 2007 Apr 16; 204(4):759-69. PubMed ID: 17420266
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H, Crockford TL, Silver K, Rust N, Goodnow CC, Cornall RJ.
    Eur J Immunol; 2005 Dec 16; 35(12):3655-63. PubMed ID: 16278813
    [Abstract] [Full Text] [Related]

  • 9. CD22 serves as a receptor for soluble IgM.
    Adachi T, Harumiya S, Takematsu H, Kozutsumi Y, Wabl M, Fujimoto M, Tedder TF.
    Eur J Immunol; 2012 Jan 16; 42(1):241-7. PubMed ID: 21956693
    [Abstract] [Full Text] [Related]

  • 10. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.
    Arthritis Rheum; 2003 Jun 16; 48(6):1612-21. PubMed ID: 12794829
    [Abstract] [Full Text] [Related]

  • 11. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ, McLean PA, Neel BG, Wortis HH.
    J Immunol; 1997 Nov 01; 159(9):4233-43. PubMed ID: 9379018
    [Abstract] [Full Text] [Related]

  • 12. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S.
    Curr Dir Autoimmun; 2005 Nov 01; 8():55-90. PubMed ID: 15564717
    [Abstract] [Full Text] [Related]

  • 13. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
    Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF.
    Nat Immunol; 2004 Oct 01; 5(10):1078-87. PubMed ID: 15378059
    [Abstract] [Full Text] [Related]

  • 14. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
    Toda M, Akita K, Inoue M, Taketani S, Nakada H.
    Biochem Biophys Res Commun; 2008 Jul 18; 372(1):45-50. PubMed ID: 18474217
    [Abstract] [Full Text] [Related]

  • 15. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF, Tuscano J, Sato S, Kehrl JH.
    Annu Rev Immunol; 1997 Jul 18; 15():481-504. PubMed ID: 9143697
    [Abstract] [Full Text] [Related]

  • 16. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.
    Nitschke L, Lajaunias F, Moll T, Ho L, Martinez-Soria E, Kikuchi S, Santiago-Raber ML, Dix C, Parkhouse RM, Izui S.
    Int Immunol; 2006 Jan 18; 18(1):59-68. PubMed ID: 16291654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
    Toda M, Hisano R, Yurugi H, Akita K, Maruyama K, Inoue M, Adachi T, Tsubata T, Nakada H.
    Biochem J; 2009 Feb 01; 417(3):673-83. PubMed ID: 18925876
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
    Mihaylova N, Voynova E, Tchorbanov A, Dolashka-Angelova P, Bayry J, Devreese B, Kaveri S, Vassilev T.
    Mol Immunol; 2009 Nov 01; 47(1):123-30. PubMed ID: 19243823
    [Abstract] [Full Text] [Related]

  • 20. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
    Mizuno K, Tagawa Y, Watanabe N, Ogimoto M, Yakura H.
    Eur J Immunol; 2005 Feb 01; 35(2):644-54. PubMed ID: 15668918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.